Literature DB >> 18821620

Three-dimensional fast spoiled gradient-echo dual echo (3D-FSPGR-DE) with water reconstruction: preliminary experience with a novel pulse sequence for gadolinium-enhanced abdominal MR imaging.

Russell N Low1, Neeraj Panchal, Anthony T Vu, Adrian Knowles, Lloyd Estkowski, Zachary Slavens, Jingfei Ma.   

Abstract

PURPOSE: To compare three-dimensional fast spoiled gradient-echo dual-echo (3D-FSPGR-DE) with water reconstruction to conventional 3D-FSPGR for gadolinium-enhanced abdominal imaging.
MATERIALS AND METHODS: Sixty-five patients underwent abdominal MRI on a 1.5T GE-HDx MR scanner using gadolinium-enhanced 3D-FSPGR and 3D-FSPGR-DE imaging. Qualitatively, FSPGR-DE and 3D-FSPGR images were reviewed side by side for normal anatomic structures, artifacts, and image quality. The images were reviewed separately for abnormalities of abdominal organs. Receiver operating characteristic (ROC) curve analysis was performed. Quantitative analysis measured mean signal intensity of liver, spleen, aorta, liver lesions, and noise.
RESULTS: Observers preferred FSPGR-DE for evaluating liver, vessels, muscles, and subcutaneous tissues. Fat suppression was superior on FSPGR-DE in 63 (0.97) and 61 (0.94) of 65 cases for two observers. FSPGR-DE showed less susceptibility artifact in 47 (0.72) and 41 (0.63) cases, better signal in edge slices in 60 (0.92) and 60 (0.92) cases, less phase artifact in 42 (0.65) and 45 (0.69) cases, and less parallel imaging artifact in 13 (0.20) and 10 (0.15) cases. Images were equivalent for depicting abdominal findings with no difference in the area under the ROC curve. FSPGR-DE images showed a 20%, 29%, and 34% increase in liver, splenic, and aortic signal, respectively, and a 45% and 62% increase in liver-lesion contrast and contrast-to-noise ratio (CNR), respectively.
CONCLUSION: Gadolinium-enhanced 3D-FSPGR-DE with water reconstruction provides volumetric abdominal imaging with superior image quality, more homogeneous fat suppression, reduced artifacts, and improved image signal and homogeneity. (c) 2008 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18821620     DOI: 10.1002/jmri.21545

Source DB:  PubMed          Journal:  J Magn Reson Imaging        ISSN: 1053-1807            Impact factor:   4.813


  6 in total

1.  The Dixon technique and the frequency-selective fat suppression technique in three-dimensional T1 weighted MRI of the liver: a comparison of contrast-to-noise ratios of hepatocellular carcinomas-to-liver.

Authors:  Y Takatsu; T Akasaka; T Miyati
Journal:  Br J Radiol       Date:  2015-04-02       Impact factor: 3.039

2.  Usefulness of two-point Dixon fat-water separation technique in gadoxetic acid-enhanced liver magnetic resonance imaging.

Authors:  Ying Ding; Sheng-Xiang Rao; Cai-Zhong Chen; Ren-Chen Li; Meng-Su Zeng
Journal:  World J Gastroenterol       Date:  2015-04-28       Impact factor: 5.742

Review 3.  Preoperative and surveillance MR imaging of patients undergoing cytoreductive surgery and heated intraperitoneal chemotherapy.

Authors:  Russell N Low
Journal:  J Gastrointest Oncol       Date:  2016-02

4.  ISMRM workshop on fat-water separation: insights, applications and progress in MRI.

Authors:  Houchun Harry Hu; Peter Börnert; Diego Hernando; Peter Kellman; Jingfei Ma; Scott Reeder; Claude Sirlin
Journal:  Magn Reson Med       Date:  2012-06-12       Impact factor: 4.668

5.  Diagnostic performance of 64-MDCT and 1.5-T MRI with high-resolution sequences in the T staging of gastric cancer: a comparative analysis with histopathology.

Authors:  M Anzidei; A Napoli; F Zaccagna; P Di Paolo; C Zini; B Cavallo Marincola; D Geiger; C Catalano; R Passariello
Journal:  Radiol Med       Date:  2009-09-22       Impact factor: 3.469

6.  A method for automatic identification of water and fat images from a symmetrically sampled dual-echo Dixon technique.

Authors:  Moiz Ahmad; Yinan Liu; Zachary W Slavens; Russell Low; Elmar Merkle; Ken-Pin Hwang; Anthony Vu; Jingfei Ma
Journal:  Magn Reson Imaging       Date:  2010-01-12       Impact factor: 2.546

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.